Dr. Romain Lazor
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients (NCT04976036) | Dr. Romain Lazor | 2022-05-05 |
Track Dr. Romain Lazor automatically
Every clearance here is in the API, with alerts when new ones post.